This suggests that the injection of IL-10-treated SVFs into the adipose tissue of diabetic mice suppresses gluconeogenic gene expression and insulin resistance through IL-10/STAT3 signaling in the liver. The gene discussed is STAT3; the disease is Insulin resistance.